trending Market Intelligence /marketintelligence/en/news-insights/trending/QO_hg5a61Ys6GXQoGXjcQQ2 content esgSubNav
In This List

Carl Zeiss Meditec books 13.9% YOY hike in fiscal 2019 revenue

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Carl Zeiss Meditec books 13.9% YOY hike in fiscal 2019 revenue

Carl Zeiss Meditec AG said revenue for fiscal year 2019 rose 13.9% year over year to €1.46 billion.

Revenue for the prior fiscal year was €1.28 billion.

The Jena, Germany-based medical technology company booked €1.07 billion in revenue in its ophthalmic devices strategic business unit, a 14.5% year-over-year rise from €933.2 million. The increase was mainly attributable to laser systems for vision correction, as well as devices and consumables for cataract surgery.

In the microsurgery division, revenue saw a 12.4% hike to €390.7 million from €347.6 million, with continued growth in sales of visualization systems for neurosurgeons, for the treatment of tumors and vascular diseases.

Carl Zeiss Meditec reported EBIT of €264.7 million during the fiscal year, up on an annual basis from €197.1 million. EBIT margin for fiscal 2019 was 18.1%, compared to the prior year's 15.4%.

For fiscal year 2020, the company anticipates EBIT margin to be between 17% and 19%.